Items where authors include "Collinson, F"

Article

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Samson, A orcid.org/0000-0002-3081-7850, West, EJ orcid.org/0000-0001-7449-120X, Carmichael, J et al. (27 more authors) (2022) Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients. Cancer Immunology Research, 10 (6). pp. 745-756. ISSN 2326-6066

Seligmann, JF, Fisher, DJ, Brown, LC et al. (19 more authors) (2021) Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring. Journal of Clinical Oncology, 39 (33). pp. 3705-3715. ISSN 0732-183X

Adams, RA, Fisher, DJ, Graham, J et al. (19 more authors) (2021) Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial. Journal of Clinical Oncology. JCO.21.01436-JCO.21.01436. ISSN 0732-183X

Walls, GM, Oughton, JB orcid.org/0000-0002-2047-804X, Chalmers, AJ et al. (20 more authors) (2020) CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer. Clinical and Translational Radiation Oncology, 25. pp. 61-66. ISSN 2405-6308

Franks, KN, McParland, L, Webster, J et al. (21 more authors) (2020) SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resection. European Respiratory Journal. ISSN 0903-1936

Collinson, F, Brown, S, Buckley, H orcid.org/0000-0002-9829-5817 et al. (11 more authors) (2018) PRISM: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. Annals of Oncology (Part of special issue:Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany), 29 (8). viii331-viii331. ISSN 0923-7534

Brown, SR, Sherratt, D, Booth, G et al. (4 more authors) (2017) Experiences of Establishing an Academic Early Phase Clinical Trials Unit. Clinical Trials, 14 (4). pp. 349-356. ISSN 1740-7745

Snee, MP, McParland, L, Collinson, F et al. (10 more authors) (2016) The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Pilot and Feasibility Studies, 2 (1). 5.

Green, BL, Marshall, HC, Collinson, F et al. (4 more authors) (2013) Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. British Journal of Surgery, 100 (1). 75 - 82. ISSN 0007-1323

Perren, TJ orcid.org/0000-0001-8472-8856, Swart, AM, Pfisterer, J et al. (23 more authors) (2011) A Phase 3 Trial of Bevacizumab in Ovarian Cancer. New England Journal of Medicine, 365. pp. 2484-2496. ISSN 0028-4793

Brown, SR, Gregory, WM, Twelves, CJ et al. (5 more authors) (2011) Designing phase II trials in cancer: a systematic review and guidance. British Journal of Cancer, 105 (2). 194 - 199 . ISSN 1532-1827

Conference or Workshop Item

Vasudev, NS orcid.org/0000-0001-8470-7481, Ainsworth, G, Brown, S orcid.org/0000-0002-7975-7537 et al. (17 more authors) (2021) LBA29 Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM). In: ESMO Congress 2021, 16-21 Sep 2021, Virtual.

Proceedings Paper

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Ralph, C et al. (17 more authors) (2021) STAR: A randomised multi-stage phase II/III trial of standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal Cancer (RCC). In: Annals of Oncology. ESMO Congress 2021, 16-21 Sep 2021, Paris, France. Elsevier , S1303-S1304.

Samson, A orcid.org/0000-0002-3081-7850, West, E, Turnbull, S et al. (13 more authors) (2019) 1213P: Single intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumor immunity. In: Abstract Book of the 44th ESMO Congress. European Society for Medical Oncology (ESMO) 2019 Congress, 27 Sep - 01 Oct 2019, Barcelona, Spain. Oxford University Press , v475-v532.

Bestall, JC orcid.org/0000-0001-6765-6379, Franks, KN, Collinson, F et al. (7 more authors) (2017) Exploring Recruitment Factors in a Feasibility Trial of SABR versus Surgery. In: Journal of Thoracic Oncology. IASLC 17th World Conference on Lung Cancer (IASLC WCLC 2016), 03-07 Dec 2016, Vienna. Elsevier , S1093-S1093.

Green, BL, Marshall, HC, Collinson, F et al. (2 more authors) (2013) Long term follow-up of the mrc conventional versus laparoscopically assisted resection in colorectal cancer trial. In: British Journal of Surgery. Annual Meeting of the Society of Academic and Research Surgery, 09-10 Jan 2013, RSM, London. Wiley , 9 - 9.